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Abstract The Class III nucleotide cyclases are found in bac-
teria, eukaryotes and archaebacteria. Our survey of the bacte-
rial and archaebacterial genome and plasmid sequences identi-
¢ed 193 Class III cyclase genes in only 29 species, of which we
predict the majority to be adenylyl cyclases. Interestingly, sev-
eral putative cyclase genes were found to have non-conserved
substrate specifying residues. Ancestors of the eukaryotic C1-
C2 domain containing soluble adenylyl cyclases as well as the
protist guanylyl cyclases were found in bacteria. Diverse do-
mains were fused to the cyclase domain and phylogenetic anal-
ysis indicated that most proteins within a single cluster have
similar domain compositions, emphasising the ancient evolution-
ary origin and versatility of the cyclase domain.
' 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Adenylyl and guanylyl cyclases are important enzymes that
catalyse the formation of second messengers that regulate
several signalling pathways. The ability to generate cAMP
from ATP is shared by six di¡erent families of proteins that
have no sequence similarity with each other [1]. Class I en-
zymes are involved in regulation of catabolite repression in
enteric bacteria [1]. The second class comprises the toxins
secreted by pathogens such as Bacillus anthracis, Bordetella
pertussis and Pseudomonas aeruginosa [1]. Class III cyclases
are found in bacteria, archaea and eukaryotes and therefore
this class has also been called the ‘Universal Class’ [1]. Mam-
malian guanylyl and adenylyl cyclases share a high degree of
sequence similarity and are members of this class, since the
nucleotide speci¢city appears to be selected by a few residues
that allow binding of either the adenine or the guanine purine
rings [2,3]. The Classes IV, V and VI of nucleotide cyclases are
exempli¢ed by cyclases from Aeromonas hydrophila, Prevotella
ruminicola and Rhizobium etli respectively [1,4,5].
The Class III cyclases are the best studied, both biochemi-
cally and structurally. A metal co-factor, usually Mg2þ or
Mn2þ, is required for catalysis [2]. Structure elucidation of a
mammalian Class III adenylyl cyclase showed that the cata-
lytic site is formed at the interface of head-to-tail dimerisation
of two Class III cyclase domains [2]. In eukaryotic adenylyl
cyclases, there are two tandem cyclase domains (C1 and C2)
within the polypeptide chain, which come together to form the
active site. Since these two cyclases domains are similar to
each other but not identical, they give rise to only a single
active site [2]. As seen in the crystal structure, the second
(pseudo-symmetric) site is occupied by the adenylyl cyclase
activator, forskolin [2]. The two metal atoms required for ca-
talysis are co-ordinated by two conserved aspartate residues
found in the C1 domain [6], and the transition state is stabi-
lised by a critical asparagine-arginine pair present in the C2
domain [7]. Mutations in these residues lead to inactivation of
the enzyme [8]. Thus, residues can be classi¢ed as C1-like or
C2-like, especially when describing corresponding residues in
the homodimeric eukaryotic receptor guanylyl cyclases (Fig.
1A) [2].
Substrate speci¢city, as deduced from the crystal structure
of the adenylyl cyclase and homology modelling of guanylyl
cyclases, identi¢ed a lysine-aspartate pair of residues in ade-
nylyl cyclases that are responsible for ATP binding, while
guanylyl cyclases contained glutamate and cysteine residues
at equivalent positions [9]. In addition, a glutamine residue
found in mammalian adenylyl cyclases (correspondingly an
arginine in guanylyl cyclases) has been shown to play an ac-
cessory role in substrate selection [9^11]. The substrate spec-
ifying pair of residues are present in the C2 domain of ade-
nylyl cyclases and the L-subunit of the heterodimeric soluble
guanylyl cyclases [9^11]. Additional residues have also been
implicated in determining substrate speci¢city [12].
Several bacterial Class III cyclases have been characterised,
and the role of cAMP in the pathogenesis of two important
bacterial diseases, pertussis and anthrax, is well understood
[13,14]. The aetiological agents of these diseases operate by
raising cAMP levels in the host cytosol by means of a secreted
adenylyl cyclase toxin. Cyclic AMP was shown to regulate
virulence pathways in Pseudomonas [15] and sporulation in
Myxococcus [16]. There are also reports of the role of
cAMP in the survival of Mycobacterium microti within phag-
olysosomes [17,18]. To our knowledge, there is no comprehen-
sive inventory available of the Class III cyclases found in
bacterial and archaebacterial genomes, with particular refer-
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ence to the presence of critical catalytic and substrate specify-
ing residues, and associated domain fusions. In this review, we
summarise our analysis of all completed bacterial and archae-
al genomes and plasmid sequences for the presence of Class
III cyclases. Based on the biochemical and structural informa-
tion on Class III cyclases, we predict whether these putative
genes are likely to be active and also comment on their sub-
strate speci¢city.
2. Analysis procedures
A combined dataset, consisting of 380 896 predicted pro-
teins from 129 genomes (113 bacterial and 16 archaebacterial)
and 456 plasmids (436 plasmids from 227 bacterial species and
20 plasmids from 11 archaebacterial species), was used for our
analysis. A combination of sensitive search methods such as
PSI-BLAST [19] and HMM [20] were utilised, and each of the
24 cyclase domain seed sequences in the Class III cyclase
HMM (Pfam accession PF00211) of the Protein Families Da-
tabase of Alignments and Models [21] was used individually in
PSI-BLAST searches until convergence at a stringent inclu-
sion value (h) cut-o¡ of 1034. In addition the catalytic domain
of Rv1625c, which we have earlier reported to perform better
[22], was also used as a PSI-BLAST query. In HMM based
searches, the Pfam accession number 00211, corresponding to
the Class III cyclase alignment, was used as the model at
expectation (E) value cut-o¡ of 1031. Additional models
were also generated for the searches.
The crystal structures of the canine type V cyclase C1 and
the rat type II C2 domains have identi¢ed residues that are
involved in interacting with the metal ion as well as substrate
speci¢city [2]. Proteins that have the two critical metal binding
aspartate residues (glutamate substitution was allowed) as
well as the transition state stabilising asparagine/glycine-argi-
nine (arginine to lysine substitution was allowed) pair are
considered to be active nucleotide cyclases. Variations in sub-
strate speci¢city residues have been observed in several en-
zymes and these have been used in our predictions of the
catalytic activity of uncharacterised proteins. Thus, a pairing
of lysine/glutamine/aspartate with either aspartate/serine/
threonine has been observed in adenylyl cyclases (Fig. 1B)
[2,23,24]. An arginine substitution for a lysine was allowed
in classifying the proteins as an adenylyl cyclase. In guanylyl
cyclases, a glutamate and cysteine/glycine/alanine/histidine/
threonine/serine have been seen as being able to support gua-
nylyl cyclase activity (Fig. 1B) [3,25^27]. However, as de-
scribed below and suggested by others recently [28], the use
of only these residues for substrate speci¢city prediction may
be insu⁄cient and additional amino acids at these positions
may confer nucleotide speci¢city. Proteins with any other res-
idue pairs present in cyclases, but that have the other catalytic
residues described above, are labelled as ambiguous cyclases
in the following analysis. Cyclase domains lacking critical ac-
tive site residues have been sub-divided based on the presence
of C1-like (two metal binding acidic residues) or C2-like (as-
paragine/glycine and arginine/lysine) residues as per the roles
identi¢ed in several enzymes. In some cases, domains did not
appear to contain C1- or C2-like functional residues, and are
therefore referred to as cyclase-like domains (Fig. 1B).
3. Bacterial nucleotide cyclases
A total of 190 Class III nucleotide cyclase domain contain-
ing proteins are identi¢able in genomes as well as in plasmids
(see later) in bacteria. Table 1 shows the distribution of cy-
clase domains in bacteria and archaea and their predicted
substrate speci¢city and catalytic function. Bradyrhizobium
japonicum, Sinorhizobium meliloti, Mesorhizobium loti, Agro-
bacterium tumefaciens and Caulobacter crescentus are classi¢ed
together (K-Proteobacteria) and show a total of 90 cyclases
encoded in their genomes (Table 1). A few proteins were iden-
ti¢ed that have a cyclase domain that is predicted to be in-
Fig. 1. Schematic representation of the critical Class III cyclase domain residues. A: Homodimeric cyclases (e.g. mammalian receptor guanylyl
cyclases) have two active sites due to the presence of all residues required for catalysis in a single polypeptide chain. The heterodimeric cyclases
(e.g. mammalian membrane bound adenylyl cyclases) have only a single catalytic centre. The NTP molecule is shown schematically at the active
site and the metal atoms are shown as black spheres. Interactions between the nucleotide, metal and the protein are indicated by dotted lines.
M1 and M2, metal binding residues; S1 and S2, substrate specifying residues; T1 and T2, transition state stabilising residues. B: A representa-
tive Class III cyclase domain indicating the positions of the two metal binding (M1 and M2), substrate specifying (S1 and S2) and transition
state stabilising (T1 and T2) residues. The amino acids allowed at each position are shown. AC, adenylyl cyclases; GC, guanylyl cyclases; C1,
cyclase domains containing only the C1-like residues; C2, cyclase domains containing only the C2-like residues. Cyclases with residues at posi-
tions S1 and S2 other than those found in the AC and GC groups, but having the permitted residues at the other positions, have been grouped
as ambiguous cyclases. Cyclase domains that lack the canonical residues at positions M1, M2, T1 or T2 are grouped as cyclase-like domains.
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active (Table 1) and additionally three truncated proteins,
possibly representing pseudogenes, were also found
(gij16264413, gij16264510 and gij27382802). Two cyclases
from S. meliloti have been characterised through complemen-
tation (gi15964943) [23] and by heterologous expression in
Escherichia coli (gi15964012) earlier [24]. Interestingly, it was
shown that a strain of S. meliloti lacking both these cyclases
was still capable of producing cAMP indicative of the pres-
ence of additional cyclase(s) [23].
A Class III cyclase from P. aeruginosa (gij15598413) was
characterised [15] and has the multi-transmembrane MASE-2
(membrane associated sensor-2) domain [29]. This domain is
associated with several GGDEF domain proteins in bacteria,
and this is interesting in view of the fact that the GGDEF
domain is homologous to the Class III cyclase domain [29],
suggesting an early fusion of the MASE-2 domain and pro-
teins that are likely to be similar in structure to the cyclase
domain. The similar MASE-1 domain is found associated
with receptor histidine kinases. While the nature of the signals
sensed by the MASE domains is unknown, it is interesting to
note that these domains are found in proteins that are in-
volved in signalling, and therefore could transduce an envi-
ronmental signal to an intracellular response.
The dissimilatory metal reducing bacteria [30] are capable
of accepting various metal atoms as terminal electron accep-
tors and are important in bioremediation. Cyclic AMP in one
such organism, Shewanella oneidensis, is required for anaero-
bic respiration [31] and a Class III cyclase could play a role in
regulating cAMP levels (Table 1). The cyclase domain con-
taining protein in the two plant pathogenic Xanthomonas spe-
cies has C1-like residues (gij21241033 and gij21229718; Table
1) and the transition state stabilising asparagine residue is
replaced by proline, while the arginine residue is conserved.
In order for this protein to be active, it would need to hetero-
Table 1
Distribution of Class III nucleotide cyclase domains in bacteria and archaebacteria
Kingdom Clade Organism AC AmbiCyc C1 C2 Cyclike Total
Bacteria K-Proteobacteria Agrobacterium tumefaciens 3 3
Agrobacterium tumefaciens str. C58 (U.
Washington)
3 3
Bradyrhizobium japonicum* 26 4 5 1 2 37
Caulobacter crescentus CB15* 1 2 1 3
Mesorhizobium loti 7 3 2 1 13
Sinorhizobium meliloti 23KL 2K 4KL 1L 1L 31
L-Proteobacteria Nitrosomonas europaea ATCC 19718 2 1 3
Q-Proteobacteria Coxiella burnetii RSA 493 1 1
Pseudomonas aeruginosa PA01 1 1
Shewanella oneidensis MR-1 1 1
Xanthomonas axonopodis pv. citri str. 306 1 1
Xanthomonas campestris pv. campestris str.
ATCC 33913
1 1
Actinobacteria Arthrobacter nicotinovoransa 2 1 3
Corynebacterium e⁄ciens YS-314 1 1
Corynebacterium glutamicum ATCC 13032 1 1
Mycobacterium bovis subsp. bovis AF2122/97 8 2 3 3 16
Mycobacterium leprae 3 1 4
Mycobacterium tuberculosis CDC1551 9 2 3 3 17
Mycobacterium tuberculosis H37Rv 8 2 3 3 16
Streptomyces avermitilis MA-4680 1 1
Streptomyces coelicolor A3(2) 1 1
Cyanobacteria Nostoc sp. PCC 7120 6 6
Synechocystis sp. PCC 6803b 1 1 3b
Thermosynechococcus elongatus BP-1 1 1 2
Spirochaetes Leptospira interrogans serovar lai str. 56601* 16 1 1 1 18
Treponema pallidum 1 1
Others Fusobacterium nucleatum subsp. nucleatum
ATCC 25586
1 1
Chlorobium tepidum TLS 1 1
Nitrosomonas europaea 2 1 3
Archaebacteria Euryarchaeota Methanosarcina acetivorans str. C2A 1 1
Methanopyrus kandleri 1 1
Methanothermobacter thermoautotrophicus 1 1
Grand total 123 21 29 4 18 193
Abbreviations: AC, adenylyl cyclase; AmbiCyc, ambiguous cyclase; C1, cyclase domain with C1-like functional residues; C2, cyclase domain
with C2-like functional residues; Cyclike, cyclase domain lacking both C1-like and C2-like residues.
Proteins identi¢ed in the study were classi¢ed as described in Section 2 and numbers of each type of cyclase domain in di¡erent genomes are
enlisted. The row totals indicate the number of genes identi¢ed in each genome and genomes marked by an asterisk have one gene that has
two cyclase domains. Therefore the cyclase domain tally in these organisms is one more than the total number of cyclase genes identi¢ed. The
numbers in the last row therefore add up to 195 cyclase domains that are present in a total of 193 gene products. One gene product is a char-
acterised guanylyl cyclase and is not listed (see below). A detailed listing of the gene identi¢cation (gi) numbers is available from the authors
on request and at www.mrdg.iisc.ernet.in/bundle/.
K and L indicate that some cyclases are present on the pSymA and pSymB mega-plasmids of S. meliloti respectively.
aThe cyclases found in this organism are present on a catabolic plasmid.
bOne cyclase in Synechocystis is the only known bacterial guanylyl cyclase (gij16329561) and is not listed in the above table. The total number
of cyclases in this genome is therefore three.
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dimerise to provide C2-like residues for nucleotide binding at
the catalytic site. However, given the lack of any other puta-
tive cyclase-like gene in the genome, it might be possible that
the homodimer is active as a consequence of additional muta-
tions that could provide a functional catalytic centre.
Coxiella burnetii, which resides in phagolysosomal vacuoles
and is the agent of human Q fever [32], is predicted to have a
cyclase (gij29654377) that is C1-like due to the substitution of
the transition state stabilising arginine residue by glycine. The
Institute for Genome Research (TIGR) annotation reveals the
presence of a frameshift truncated Class III cyclase gene
(gij29541643) in this organism as well [33]. C. burnetii is an
obligate intracellular pathogen with a reduced genome size
and several pseudogenes and it is possible that it has lost
cyclase genes in this process of gene degradation [32]. Inter-
estingly, Pseudomonas, Shewanella, Xanthomonas and Coxiella
are classi¢ed as Q-Proteobacteria and have only a single Class
III cyclase in their genomes, unlike the K-Proteobacteria
which have multiple Class III cyclase domains in their ge-
nomes (Table 1).
The Actinobacteria such as Mycobacterium, Corynebacte-
rium, Streptomyces and Arthrobacter have signi¢cant medical
and industrial importance and constitute a group with a large
number (60 in all) of cyclases (Table 1). Many of these organ-
isms were found to have Class III cyclases and cyclase-like
putative regulatory domains (Table 1). Several cyclase-like
domains were found fused to an ATPase and a helix-turn-
helix type DNA binding domain (Fig. 2) and such domain
organisation is unique to the Actinobacteria. These transcrip-
tion factor-like and other actinobacterial cyclases have been
described in greater detail elsewhere and will not be discussed
here [22].
Cyclic AMP in Cyanobacteria is known to regulate hetero-
cyst patterns [34], respiration and gliding [35], and its levels
are known to change in response to changes in light and pH
[36,37]. Several cyanobacterial cyclases have been studied bio-
chemically [38^45]. Extensive biochemical characterisation by
cloning, expression and puri¢cation has been carried out on a
cyclase, CyaC, from Spirulina which shows intricate regula-
tion of the cyclase activity by a two-component phosphoryla-
tion event [45]. The adenylyl cyclase, CyaG, from Spirulina
has guanylyl cyclase-like dimerisation regions N-terminal to
the cyclase domain and greater sequence similarity to guanylyl
cyclases [40]. Site-directed mutagenesis of substrate specifying
residues in this enzyme could convert it to a guanylyl cyclase,
indicating that this enzyme appeared to possess the structural
features required of a guanylyl cyclase. In this context, it is
interesting to note that the Rv1625c gene product from My-
cobacterium tuberculosis could not be converted to a guanylyl
cyclase by mutation, despite its overall higher sequence sim-
ilarity to a guanylyl cyclase, again emphasising the subtle
changes in amino acids and, as a consequence, the structures
of closely related bacterial Class III cyclases.
Six Class III cyclases from Anabaena spp. (now Nostoc)
were cloned through a genetic screen [42] and have been iden-
ti¢ed in the genome analysis described here (Table 1), and one
of them has similar domain fusions described for the Spirulina
platensis CyaC enzyme [45]. A GAF (cGMP speci¢c phospho-
diesterase, adenylyl cyclase and FhlA) domain containing cy-
clase from Anabaena [38] is interesting in that it is regulated
by cAMP binding to one of its two N-terminal GAF domains,
suggesting a positive feed-back for regulation of its enzymatic
activity. To date, no such domain fusion has been observed in
any cyclase from higher organisms.
Spirochaetes are a group of bacteria with a unique cellular
structure and are agents of diseases such as Lyme disease,
syphilis and leptospirosis [46]. The three Spirochaete genome
sequences available [47^49] show a stark contrast as far as the
presence of Class III cyclase genes. Thus, Leptospira interrog-
ans contains as many as 18 putative cyclase domains in its
genome, while the genome of Borrelia burgdorferi does not
appear to harbour any. This is obviously indicative of the
diverse nature of this small group of bacteria (Table 1) and
their adaptation to their mammalian host.
A single soluble cyclase was detected in the obligate anaer-
obe Fusobacterium nucleatum (Table 1). Chlorobium tepidum,
a photosynthetic green-sulphur bacterium that utilises sul-
phide as the electron source, also encodes a Class III cyclase
(Table 1). Both these cyclases are highly divergent members of
the cyclase domain and therefore have variations in the active
site residues. The F. nucleatum cyclase has threonine and as-
paragine residues in the place of the transition state stabilising
asparagine and arginine respectively. Nitrosospira europaea (a
L-Proteobacterium) shows the presence of three cyclase do-
main containing genes (Table 1).
4. Archaebacterial cyclases
The sequences of the cyclase domains in the three archaeal
methanogens, namely Methanosarcina, Methanopyrus and
Methanothermobacterium, are very divergent and do not allow
for the easy identi¢cation of the typical Class III cyclase cat-
alytic residues. The residues required for C2 functions are not
the conserved asparagine and arginine residues and therefore
these proteins might have interesting and unique biochemical
properties. These proteins are s 300 amino acids in length;
however, no other known domain was identi¢able in these
proteins. Cloning and biochemical characterisation of these
cyclases would be of interest.
5. Cyclases on bacterial plasmids
Plasmids are well known vehicles for horizontal gene trans-
fer and the presence of cyclases on plasmids could indicate
that this mechanism is operative in horizontal transmission of
Class III cyclase genes [50]. Our analysis shows that three
cyclase genes are present on the nicotine utilisation catabolic
plasmid of Arthrobacter nicotinovorans, a soil Actinobacte-
rium [51]. These enzymes could be possibly involved in regu-
lation of expression of genes on the large plasmid itself. The
substrate speci¢city of two active cyclases (gij25169176 and
gij25169179) is not predictable from their sequence and the
third cyclase (gij25169178) lacks critical catalytic residues and
therefore has C1-like functional residues (Table 1). The lack
of a large number of cyclases on plasmids suggests that these
may not be the main source of horizontal transfer of this
gene.
Several cyclases are present on the large plasmids (pSymA
and pSymB) found in Sinorhizobium (Table 1). However, the
size and the additional presence of several important genes on
these symbiotic plasmids fuels the debate as to whether these
plasmids should be classi¢ed as such, or are actually chromo-
somes [52].
Interestingly a cyclase from the pSymB plasmid of S. meli-
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Fig. 2. Domain compositions of Class III cyclases in bacteria and archaea. Schematic domain compositions (not to scale) of cyclases are shown based on the SMART, CD search and Pfam do-
main entries. Transmembrane regions were predicted using TMHMM2 (http://www.cbs.dtu.dk/services/TMHMM/). Proteins shown are representative of each domain composition in a genome,
and several proteins of similar domain compositions were identi¢ed as is seen in Fig. 3. The number of tetratricopeptide repeats (TPR) varies within proteins that have other domains in common
(e.g. when found along with the COG5616 and COG3899/ATPase domains) and only one representative has been shown (see Fig. 3).
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loti (gij16264509) appears to be a truncated cyclase pseudo-
gene. Full-length cyclase genes with 65^67% sequence identity
are found in M. loti (gij13472842) and Rhizobium etli
(gij21616128) respectively, possessing all residues required
for catalytic activity.
6. Eukaryotic-like double cyclase domain containing proteins
Several eukaryotic adenylyl cyclases have two cyclase do-
mains within a single polypeptide chain that associate to form
the catalytic centre [2]. In B. japonicum, a cyclase gene
(gij27376782) was found to have two tandem cyclase domains
(Fig. 2). Closer analysis of the B. japonicum protein indicates
that the N-terminal cyclase domain in the sequence (called C1
by convention) has residues that classify it functionally as a
C2 domain, and the second domain has C1-like residues. This
organisation is reminiscent of the 22-transmembrane gua-
nylyl cyclases in eukaryotic microbes such as Plasmodium
where such switching of the C1 and C2 functional domains
in the polypeptide chain was ¢rst observed [25]. A close-
ly related cyclase with switched C1 and C2 domains was
found in another K-Proteobacterium, Caulobacter crescentus
(gij16126933). This raises the interesting possibility that the
protist guanylyl cyclases could have evolved from these
double cyclase domain cyclases found in bacteria. Further
biochemical characterisation of these forerunners of mam-
malian-like cyclases and a study of di¡erences in their
biochemical properties would provide insight into the evolu-
tion of the enzymes found in higher organisms.
Another interesting case is that of a gene in L. interrogans
(gij24216707) that encodes a soluble adenylyl cyclase with C1-
like and C2-like domains arranged in tandem, similar to the
mammalian adenylyl cyclases. The cyclase domains in this
protein are followed by the COG3899 ATPase domain that
is fused C-terminal to the cyclase domains. This therefore
makes it similar in domain composition to the mammalian
testicular adenylyl cyclase (Fig. 2). It has been suggested ear-
lier that the progenitor of the mammalian testicular cyclase
must have arisen in bacteria, where the fusion of the cyclase
and an ATPase domain is found [26]. We suggest that the
bacterial double cyclase domain and ATPase containing pro-
teins are the most likely ancestors of the mammalian soluble
enzyme. These genes contain additional tetratricopeptide re-
peats (TPR) at the C-terminal region, allowing for protein^
protein interactions and formation of higher oligomers, which
are absent in the mammalian enzyme. It would be interesting
to test whether the stimulatory e¡ect of bicarbonate on the
mammalian enzyme [53] is also found in the L. interrogans
protein. The substrate specifying residues in the predicted C2
domain of this protein are a serine-threonine pair of residues,
and recently the presence of a threonine residue at the second
position was suggested to be essential for bicarbonate stimu-
lation [54].
7. Guanylyl cyclases in bacteria
There are only very early reports of the occurrence of
cGMP in bacteria and this is also re£ected in the relatively
few candidate guanylyl cyclases in bacteria and archaea. In
our analysis, only two cyclases with substrate specifying resi-
due pairs as seen in eukaryotic guanylyl cyclases (glutamate-
glycine and glutamate-threonine) are seen in the Cyanobacte-
ria Synechocystis and Nostoc. A guanylyl cyclase identi¢ed
through genetic analysis in Synechocystis (gij16329561) [27]
has four transmembrane regions, a CHASE-2 domain and
the single Class III cyclase domain, and deletion of this
gene resulted in reduced intracellular cGMP levels in the
cell. However, a thorough biochemical characterisation of
this protein would be a fruitful area of study, since no direct
measure of the catalytic activity of the puri¢ed gene product
has been described so far.
The similar CHASE-2 domain containing cyclase from Nos-
toc (gij17228613) that has a glutamate-threonine pair at the
substrate specifying positions has been earlier characterised
through genetic screening via complementation of an adenylyl
cyclase de¢cient strain of E. coli [42]. It is possible, however,
that at least in a subset of bacterial cyclases there may be
contributions of as yet unknown additional amino acids to-
wards substrate speci¢city. This is also apparent from the
failure of conversion of an adenylyl cyclase from M. tuber-
culosis to a guanylyl cyclase, despite high overall sequence
similarity of that protein to the guanylyl cyclases [55]. Indeed,
sequence analysis has already identi¢ed more residues that
di¡er between the mammalian adenylyl and guanylyl cyclases
that could contribute to substrate speci¢city [12].
8. Ambiguous cyclases
Several cyclases that have all the residues required for ca-
talysis but do not have either adenylyl or guanylyl cyclase-like
substrate binding residues were found and classi¢ed as a
group of ambiguous cyclases (Tables 1 and 2). Biochemical
characterisation would be required for resolution of their sta-
tus as adenylyl or guanylyl cyclases. Cloning, puri¢cation and
initial characterisation of the arginine-leucine pair containing
cyclase (gij15608031) from M. tuberculosis (Rv0891c) has in-
dicated it to be an adenylyl cyclase (unpublished observations)
and therefore represents a new substrate speci¢city pair that
allows for the conversion of ATP. This combination however
Table 2
Substrate specifying residues found in bacterial cyclases that are not
found in characterised adenylyl or guanylyl cyclases
Organism GI number S1 S2
Arthrobacter nicotinovorans gij25169179 S V
gij25169176 D V
Bradyrhizobium japonicum gij27375549 N D
gij27380748 G T
gij27375470 K A
gij27381818 R A
Caulobacter crescentus CB15 gij16126936 S V
Methanosarcina acetivorans str. C2A gij20090420 N V
Mycobacterium bovis subsp. bovis
AF2122/97
gij31791563 Q N
gij31792079 R L
Mesorhizobium loti gij13471136 G T
gij13472842 S S
gij13473854 N A
Mycobacterium tuberculosis CDC1551 gij15839770 Q N
gij15840309 R L
Mycobacterium tuberculosis H37Rv gij15607527 Q N
gij15608031 R L
Nitrosomonas europaea ATCC 19718 gij30249278 D R
Sinorhizobium meliloti gij15965819 N D
gij16263440 K G
Thermosynechococcus elongatus BP-1 gij22299823 K G
The amino acid at the S1 position corresponds to the lysine and
that at S2 to the aspartate found in most adenylyl cyclases.
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is present in only three orthologous mycobacterial proteins
(gij31792079, gij15840309, gij15608031; Table 2). A few
cyclases have lysine paired with glycine (gij22299823,
gij16263440) or alanine (gij27375470) and thus have at least
one conserved substrate speci¢city residue that is present in
adenylyl cyclases (Table 2).
9. Domain compositions of Class III cyclases
Class III cyclases in bacteria have been shown to be regu-
lated by pyruvate [56], aspartate and histidine phosphoryla-
tion [45] and cAMP [38], suggesting that domains fused to the
cyclase domain have an important regulatory role. We there-
fore have identi¢ed additional domains fused to the cyclase
domain using HMMPfam (Pfam version 9) and the IMPALA
program [57], and version 1.62 of the Conserved Domain
Database consisting of 11 088 protein family pro¢les (http://
www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi).
Representative domain compositions of the nucleotide cy-
clases identi¢ed in this study are shown in Fig. 2. A larger
variety of domain compositions is observed within genomes
that have multiple cyclases, such as the K-Proteobacteria and
the Actinobacteria (Fig. 2). A total of 119 proteins are soluble
and a majority of the membrane bound cyclases have six
transmembrane domains (30).
Within the K-Proteobacteria, there are several multidomain
proteins (Fig. 2). One such protein (gij13472512) has several
WD40 repeats (composite E value 2.3U10398) along with a
region that picks up comparatively weak stretches of similar-
ity to the £avivirus non-structural protein NS2B and a cyto-
chrome cd1 haem binding domain (E value V0.06). It is in-
teresting to note that in eukaryotic systems, the L subunit of
the heterotrimeric G proteins that along with the Q subunit
shows isoenzyme speci¢c regulation of mammalian cyclase
activity, is a prototypical protein with WD40 domain repeats
[21]. Here, in bacteria, we ¢nd a part of the cyclase domain
and the WD40 repeats within the same polypeptide chain,
thus dating back the functional relation between these two
domains to the bacteria.
A large number of cyclases, especially within the K-Proteo-
bacteria, have TPRs (Fig. 2). This domain is found in several
proteins, and is possibly involved in protein^protein interac-
tions that could regulate the oligomeric status of the proteins
[58]. Additionally, the SAM domain, involved in protein^pro-
tein interaction and formations of homo- and heteromeric
complexes [59], was also found fused to the cyclase domain.
The requirement for dimerisation for the formation of the
active site could be the reason behind the presence of domains
that allow for protein^protein interaction in cyclases. The 12-
transmembrane eukaryotic adenylyl cyclases are activated by
forskolin and GsK protein by facilitating tighter association of
the protomers [2]. Unlike these double cyclase domain en-
zymes however, the regulation of bacterial homodimeric cy-
clases might require additional mechanisms to bring the two
protomers together, and domains fused to the cyclase domain
may assist in this. Alternatively, a particularly interesting im-
plication is the possibility of generating a very large repertoire
of cyclases in organisms with multiple cyclases, by the hetero-
dimerisation of di¡erent cyclases. Moreover, the dimerisation
of an active cyclase with a cyclase domain that lacks catalytic
residues could lead to inactivation of one or both of the active
sites. Earlier, the co-expression of two receptor cyclases from
Leishmania, only one of which was active, led to a complete
loss of cyclase activity [60]. We have shown recently that the
substrate specifying residues in the Rv1625c protein of M.
tuberculosis were found to contribute to dimerisation, thus
indicating the intricate mechanisms that have evolved in reg-
ulating oligomerisation in bacterial cyclases [61].
A striking domain composition is found in the gij27376781
cyclase in B. japonicum which has a cNMP binding domain in
addition to the cyclase domain (Fig. 2). This domain probably
binds cAMP thereby allowing for allosteric modulation of the
cyclase activity, in a manner similar to the GAF domain cy-
clase from Anabaena that is activated by cAMP [38]. A novel
domain composition is found with domains involved in elec-
tron transport, such as the quinol oxidase subunit (DoxD)
and the ferredoxin (Fer2) domain containing cyclases (seven
proteins). The cyclase domains found within these proteins
(gij15889837, gij15966204, gij16263053, gij16330418,
gij17936455, gij24213884, gij27382367) are predicted to be ac-
tive as adenylyl cyclases (Table 1 and Fig. 2). The Fer2 do-
main has been implicated to bind small organic molecules or
metal ions [62]. This domain might therefore act as an allo-
steric regulator of the cyclase domain. Fusions of inactive
cyclase-like domains are also found with the KL-hydrolase
domain (Fig. 2). In this scenario it is likely that these diver-
gent cyclase domains have evolved novel regulatory functions.
They may retain the ability to bind nucleotides that could in
turn lead to the regulation of the associated e¡ector domain.
A predicted adenylyl cyclase in Nostoc, Synechocystis and
Thermosynechococcus has a forkhead associated (FHA) do-
main (gij17228238, gij16330472, gij22299953 respectively),
which is a domain involved in binding to phospho-serine
and phospho-threonine residues [63]. Interestingly, eukary-
otic-like kinases have been identi¢ed in Cyanobacteria
[64,65] and probably this could be a link between the cyclic
nucleotide and kinase signalling pathways in these organisms.
The versatile GAF, HAMP (histidine kinases, adenylyl cy-
clases, methyl accepting chemotactic receptors and phospha-
tases) as well as the histidine kinase and receiver domains are
found associated with the cyclase domain from Nostoc, and
may therefore allow the regulation of diverse functions by
cAMP in these organisms [42].
L. interrogans has four membrane bound HAMP domain
cyclases and two soluble cyclases with GAF domain fusions
(Figs. 2 and 3). Deletion and mutagenesis of HAMP domains
in proteins leads to deregulation of the downstream e¡ector
domains [66]. A large number of cyclases in M. tuberculosis
and Actinobacteria also have HAMP domains (Figs. 2 and 3).
The HAMP domain is the most commonly occurring domain
(present in 30 proteins) found fused to the catalytic domain,
followed by the ATPase domain (22 proteins) and A variable
number of TPRs (found in 21 proteins). The COG5616 and
the CHASE-2 domain were found in 14 and 11 proteins re-
spectively.
10. Phylogenetic analysis of the cyclases
A phylogenetic analysis of the cyclases was carried out us-
ing an alignment of the cyclase domains from the hits de-
scribed above excluding eight (gij13472512, gij15608260,
gij15840558, gij16264413, gij16264509, gij16264510,
gij27382802, gij31792314) truncated cyclases that could repre-
sent pseudogenes. Multiple sequence alignments were gener-
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ated using hmmalign [20] and ClustalX [67], and edited with
Jalview [http://www.jalview.org]. The phylogenetic tree repre-
sentation shown in Fig. 3 is based on the neighbour-joining
method using Molecular Evolution Genetics Analysis soft-
ware [68]. Branches with s 50% support in a 1000 replicate
interior branch test are included in the tree. The tree is drawn
and labelled to include the domains, number of predicted
transmembrane helices and the predicted nature of the do-
main classi¢ed as explained earlier.
As can be seen in Fig. 3, several proteins with similar do-
main compositions are found on neighbouring clusters, indi-
cating that these domains have co-evolved from a common
ancestor and then diverged and/or expanded within speci¢c
lineages. Cases in point are the cyclases in the branch labelled
1, which contains several cyclases with the TPR and the
COG5616 integral membrane domains. Interestingly, the
ATPase domain represented by COG3899 and the NB-ARC
(nucleotide binding domain common to Apaf1, Resistance
proteins and CED4) domain are found in cyclases in clusters
2^4. This indicates that di¡erent ATPase domains may have
fused to the cyclase domain multiple times during evolution.
The actinobacterial transcription factor-like proteins with a
cyclase domain are found in cluster 3. Cluster 5 has the six-
transmembrane HAMP domain cyclases from Actinobacteria,
close to which are found cyclases with a Fer2 or DoxD do-
main. Several cyclases from L. interrogans are found within
cluster 6, and this indicates that the cyclases in this genome
are probably related by paralogy.
The C1-like and C2-like functional domains of the double
cyclase domain containing proteins are found in separate clus-
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ters labelled 7 and 8. Note that the domains cluster based on
the functionality of these domains and not their order of
appearance in the polypeptide chain. Interestingly, cyclases
from C. crescentus and the Arthrobacter plasmid are found
in each of these two clusters. It would be interesting to test
whether the Arthrobacter enzymes act as functional hetero-
dimers. The existence of bacterial cyclases with two cyclase
domains also predates the evolution of such cyclases to bac-
teria. Moreover, the switching of C1 and C2 domain is also
found within bacteria. The distribution of such cyclases within
bacteria is limited at present, probably due to the bias in the
type of bacteria whose genomes have been sequenced. How-
ever, the identi¢cation of these eukaryotic-like proteins has
opened up new ancestral candidates of the protist guanylyl
cyclases and the mammalian soluble adenylyl cyclases.
11. Conclusions
Class III cyclases were found in relatively few (29 species) of
the 129 genomes that were surveyed. The major bacterial
groups that lack the Class III cyclases are the Bacillus/Clos-
tridium group, the Deinococcus group, the Chlamydiae, and
the O- and N-Proteobacteria. Phylogenetic trees based on mul-
tiple genes and multiple methods have yielded reference trees
for inferring phylogeny [69^71]. Based on such trees, the Class
III cyclase domains are present in most branches and appear
to be absent mainly from the ancestors of the Bacillus/Clos-
tridium group and that of the L/Q-Proteobacteria. Although
the Deinococci have been integrated with the Actinobacteria-
Cyanobacteria clade, D. radiodurans lacks the Class III cy-
clase. This organism however has 16 GGDEF domain con-
taining proteins (TIGR, http://www.tigr.org). Interestingly,
several Proteobacteria, which also lack Class III cyclases,
have multiple GGDEF domain containing proteins. The
GGDEF domain is thought to have diguanylate cyclase activ-
ity [72] but very few proteins have been biochemically char-
acterised. Indeed, the diversi¢cation and expansion of the
GGDEF domains in several bacteria that lack Class III cy-
clases stresses the need for further characterisation of these
proteins.
Class III cyclases are restricted only to a few Q-Proteobac-
teria, whose genomes encode nucleotide cyclases of the other
classes as well. This indicates the presence of the cyclase do-
main in a common ancestor and its loss or diversi¢cation in
some lineages. The presence of archaeal cyclases in several
clusters of the phylogenetic tree (Fig. 3) indicates the possible
horizontal transfer of these enzymes from bacteria. Moreover,
their presence in archaebacteria also indicates the structural
modi¢cation of the cyclase domain into that which can retain
its function even under extreme conditions.
Fusions to various domains increase the versatility of a
protein family and allow its recruitment into various cellular
regulatory pathways. Since this is seen often in cyclases within
bacteria and eukaryotes, the Class III cyclase domain itself
appears to be structurally amenable to undergoing such fu-
sions with a variety of diverse domains.
The presence of an overwhelming majority of adenylyl cy-
clases in bacteria is re£ected in only a few reported cases of
cGMP based signalling in prokaryotes. Indeed, even in eu-
karyotes such as yeast, there is no conclusive evidence to
demonstrate the use of cGMP as a second messenger. We
can only hypothesise as to the reasons for the more wide-
spread occurrence of adenylyl cyclases in all phyla. It has
been suggested that cAMP may have been the precursor for
the generation of ATP in the reverse cyclase reaction [1].
Therefore, the retention and subsequent evolution of the uti-
lisation of cAMP for signalling may have led to the ubiqui-
tous presence of cAMP rather than cGMP in most life forms.
The use of backbone peptide bond interactions in binding
ATP in the Class III adenylyl cyclases [7] has led to the gen-
eration of enzymes that are less sensitive to mutations that
abolish adenylyl cyclase activity and completely alter substrate
speci¢city. For example, mutations of the substrate specifying
residues in adenylyl cyclases resulted in a general purine cy-
clase, which could synthesise both cAMP and cGMP, while
corresponding mutations in guanylyl cyclases completely abol-
ished the ability to use GTP as a substrate, and converted the
enzyme to an adenylyl cyclase [10]. Thus, guanylyl cyclases
appear to be more specialised enzymes, with stringent struc-
tural requirements, and could have evolved later by re¢ne-
ment of the adenylyl cyclase core. Finally, the relative stability
of cGMP as compared to that of cAMP (free energy of hy-
drolysis of the 3P-phosphate bond being 310.5 kcal/mol for
cGMP and 314.1 kcal/mol for cAMP [73]) may also have
contributed to the absence of cGMP in bacteria, where a
rapid turn-over of signalling molecules is required to generate
6
Fig. 3. Phylogenetic analysis of Class III cyclases in bacteria and archaea. The topology of a neighbour-joining consensus tree with branches
having s 50% support in an interior branch test is shown. Names of genes begin with the gene identi¢er number, followed by the abbreviation
for the name of organism along with the mention of the C1 or the C2 domain (by order of appearance in the polypeptide chain) when more
than one cyclase domain was present. This is followed by an abbreviation of the other domains fused to the cyclase domain and the number
of transmembrane (tm) regions. Finally, the predicted substrate speci¢city when active, or the C1-like or C2-like nature of the domain is men-
tioned (see Section 2). Branches with numbers are described in greater detail in the text. Abbreviations used for domains are: ABH, KL-hydro-
lase; Cache, Ca channels and chemotaxis receptors; Ch, CHASE-2; cNMP bind, cNMP binding; COG3899, an ATPase; COG5616, an integral
membrane domain; DoxD, quinol oxidase subunit; DUF323, domain of unknown function-323; fer2, ferredoxin; FHA, forkhead associated;
G, GAF; H, HAMP; HATPase, histidine kinase-like ATPase; HK, histidine kinase; HTH, helix-turn-helix (HTH) type DNA binding do-
mains; M2, MASE-2; N, NB-ARC; PilF, Tfp pilus assembly protein PifF; RR, response regulator/receiver; SAM, sterile K motif; zf-Sec23
Sec24, Sec23/Sec24 zinc ¢nger; T, TPR. Names of organisms are A.nic, Arthrobacter nicotinovorans ; A.tum, Agrobacterium tumefaciens ;
A.tumC58, Agrobacterium tumefaciens str. C58 (U. Washington); B.jap, Bradyrhizobium japonicum ; C.cre, Caulobacter crescentus CB15; C.tep,
Chlorobium tepidum TLS; C.e¡, Corynebacterium e⁄ciens YS-314; C.glu, Corynebacterium glutamicum ATCC 13032; C.bur, Coxiella burnetii
RSA 493; F.nuc, Fusobacterium nucleatum subsp. nucleatum ATCC 25586; L.int, Leptospira interrogans serovar lai str. 56601; M.lot, Mesorhi-
zobium loti ; M.kan, Methanopyrus kandleri AV19; M.ace, Methanosarcina acetivorans str. C2A; M.ther, Methanothermobacter thermoautotrophi-
cus ; M.bov, Mycobacterium bovis subsp. bovis AF2122/97; M.lep, Mycobacterium leprae ; MtbCDC1551, Mycobacterium tuberculosis CDC1551;
MtbH37Rv, Mycobacterium tuberculosis H37Rv; N.eur, Nitrosomonas europaea ATCC 19718; Nos, Nostoc sp. PCC 7120; P.aer, Pseudomonas
aeruginosa PA01; S.one, Shewanella oneidensis MR-1; S.mel, Sinorhizobium meliloti ; S.ave, Streptomyces avermitilis MA-4680; S.coe, Streptomy-
ces coelicolor A3(2); Synecho, Synechocystis sp. PCC 6803; T.elo, Thermosynechococcus elongatus BP-1; T.pal, Treponema pallidum ; X.axon,
Xanthomonas axonopodis pv. citri str. 306; X.cam, Xanthomonas campestris pv. campestris str. ATCC 33913.
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quick responses. It is important to note that bacteria utilise
ppGpp and cyclic diguanylate as intracellular messengers and
further studies on enzymes that generate these molecules are
likely to prove illuminating.
The Class III cyclase domains are found in bacteria that
occupy varied ecological niches and have di¡erent physiolog-
ical prowess. These range from oxygenic and non-oxygenic
photosynthetic bacteria such as Cyanobacteria and Chlor-
obium, pathogens such as Mycobacterium leprae and M. tuber-
culosis, biotechnologically important nitrogen ¢xing K-Proteo-
bacteria, Shewanella as well as free living bacteria. However,
the presence of members of the other classes of cyclases and
the absence of the Class III domain in many bacteria [33],
indicates that perhaps evolutionary tinkering has selected for
the function of generating cAMP, rather than the Class III
cyclase fold itself. Nevertheless, the regulation by cAMP of
important secondary metabolite pathways and virulence in
several bacteria of interest to humans make the Class III
cyclase family a prominent target for structural and biochem-
ical studies. It is hoped that many of the putative cyclase
genes that we have identi¢ed in this study will provide an
impetus for biochemical characterisation and evaluation of
the roles of these enzymes in diverse bacteria.
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